Showing results (261-270 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|April 30, 2019
The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogsHong K Kim, Nicholas J Connors, Maryann E Mazer-AmirshahiExpert Opinion on Drug Safety|May 4, 2019
A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety dataSree S Kolli, Anna L Kepley, Abigail Cline, et al.Expert Opinion on Drug Safety|July 24, 2018
A safety review of proton pump inhibitors to treat acid-related digestive diseasesEdoardo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.Expert Opinion on Drug Safety|July 25, 2018
Rationale for administering beta-blocker therapy to patients undergoing coronary artery bypass surgery: a systematic reviewArushi Thaper, Alexander KulikExpert Opinion on Drug Safety|May 12, 2017
Methods for safety signal detection in healthcare databases: a literature reviewMickael Arnaud, Bernard Bégaud, Nicolas Thurin, et al.Expert Opinion on Drug Safety|May 11, 2018
A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) databaseSimon Dagenais, Richard Scranton, Andrew R Joyce, et al.Expert Opinion on Drug Safety|April 6, 2018
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?Maurizio Sessa, Concetta Rafaniello, Cristina Scavone, et al.Expert Opinion on Drug Safety|August 23, 2016
Safety of secukinumab in the treatment of psoriasisAndrew BlauveltExpert Opinion on Drug Safety|August 23, 2016
The safety and tolerability of the second-line injectable antituberculosis drugs in childrenAnthony J Garcia-Prats, H Simon Schaaf, Anneke C HesselingExpert Opinion on Drug Safety|April 7, 2018
Analyzing research trends on drug safety using topic modelingChen ZouPageof 281